These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37496643)

  • 1. Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome.
    Goudarzi RM; Badiee Z; Sadeghnia A; Barekatain B
    J Res Med Sci; 2023; 28():53. PubMed ID: 37496643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of intratracheal salbutamol in addition to surfactant on the clinical course of newborns with respiratory distress syndrome: a clinical trial.
    Dehdashtian M; Malakian A; Aramesh MR; Mazori A; Aletayeb MH; Shirani A; Bashirnejad S
    Ital J Pediatr; 2016 Jan; 42():6. PubMed ID: 26786589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effect of surfactant administration during nasal continuous positive airway pressure with that of nasal continuous positive airway pressure alone on complications of respiratory distress syndrome: a randomized controlled study.
    Nakhshab M; Tajbakhsh M; Khani S; Farhadi R
    Pediatr Neonatol; 2015 Apr; 56(2):88-94. PubMed ID: 25264154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung recruitment improves the efficacy of intubation-surfactant-extubation treatment for respiratory distress syndrome in preterm neonates, a randomized controlled trial.
    Yang Y; Yan W; Ruan M; Zhang L; Su J; Deng H; Li M
    BMC Pediatr; 2022 Jan; 22(1):14. PubMed ID: 34980047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge.
    Nayeri FS; Esmaeilnia Shirvani T; Aminnezhad M; Amini E; Dalili H; Moghimpour Bijani F
    Acta Med Iran; 2014; 52(8):596-600. PubMed ID: 25149882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Harrington EW; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial.
    Mishra A; Joshi A; Londhe A; Deshmukh L
    Pediatr Pulmonol; 2023 Mar; 58(3):738-745. PubMed ID: 36416036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less Invasive Surfactant Administration (LISA) vs. Intubation Surfactant Extubation (InSurE) in Preterm Infants with Respiratory Distress Syndrome: A Pilot Randomized Controlled Trial.
    Pareek P; Deshpande S; Suryawanshi P; Sah LK; Chetan C; Maheshwari R; More K
    J Trop Pediatr; 2021 Aug; 67(4):. PubMed ID: 34595526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of a novel double-lumen tracheal tube in neonates with RDS: A prospective cohort study.
    Li C; Du Y; Yang K; Cao H; Yang H; Zhang C; Li X; Deng X; Shi Y
    Front Pediatr; 2022; 10():1032044. PubMed ID: 36545664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
    Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
    BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early surfactant therapy with nasal continuous positive airway pressure or continued mechanical ventilation in very low birth weight neonates with respiratory distress syndrome.
    Najafian B; Fakhraie SH; Afjeh SA; Kazemian M; Shohrati M; Saburi A
    Iran Red Crescent Med J; 2014 Apr; 16(4):e12206. PubMed ID: 24910785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of inhalation of pulmonary surfactant using vibrating mesh nebulizers combined with nasal continuous positive airway pressure in the treatment of neonatal respiratory distress syndrome].
    Gao Y; Chen X; Zhang Z; Qu S; Sang X; Wu Y; Zhou R; Peng W; Chen Y; Wang Y; Zhuo F; Chen L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jan; 34(1):80-84. PubMed ID: 35307066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Inhaled Budesonide on the Prevention of Chronic Lung Disease in Premature Neonates with Respiratory Distress Syndrome.
    Sadeghnia A; Beheshti BK; Mohammadizadeh M
    Int J Prev Med; 2018; 9():15. PubMed ID: 29541430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant therapy in premature babies: SurE or InSurE.
    Jena SR; Bains HS; Pandita A; Verma A; Gupta V; Kallem VR; Abdullah M; Kawdiya A; On Behalf Of Sure Group
    Pediatr Pulmonol; 2019 Nov; 54(11):1747-1752. PubMed ID: 31424177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
    Gupta BK; Saha AK; Mukherjee S; Saha B
    Eur J Pediatr; 2020 Aug; 179(8):1287-1293. PubMed ID: 32462483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.